CN1133654C - 灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物及其用途和制备方法 - Google Patents

灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物及其用途和制备方法 Download PDF

Info

Publication number
CN1133654C
CN1133654C CNB99116590XA CN99116590A CN1133654C CN 1133654 C CN1133654 C CN 1133654C CN B99116590X A CNB99116590X A CN B99116590XA CN 99116590 A CN99116590 A CN 99116590A CN 1133654 C CN1133654 C CN 1133654C
Authority
CN
China
Prior art keywords
alpha
dextran
ganoderic
aqueous solution
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB99116590XA
Other languages
English (en)
Other versions
CN1283633A (zh
Inventor
张俐娜
陈敬华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan University WHU
Original Assignee
Wuhan University WHU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan University WHU filed Critical Wuhan University WHU
Priority to CNB99116590XA priority Critical patent/CN1133654C/zh
Publication of CN1283633A publication Critical patent/CN1283633A/zh
Application granted granted Critical
Publication of CN1133654C publication Critical patent/CN1133654C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

本发明公开了具有抗肿瘤活性的灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物的制备方法。该方法用碱水溶液首次从灵芝子实体中提取出水不溶性线型α-(1→3)-D-葡聚糖，该多糖不具有抗肿瘤活性。将α-(1→3)-D-葡聚糖溶解在NaOH水溶液中，用氯乙酸钠水溶液在80℃对其羧甲基化6-8小时制备了该多糖的羧甲基衍生物。这种衍生物是水溶性的，对植入小鼠体内的爱氏腹水瘤(EAC)的生长具有明显的抑制作用，并且无毒副作用。

Description

灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物 及其用途和制备方法
本发明涉及一种具有抗肿瘤活性的α-(1→3)D-葡聚糖羧甲基化衍生物及其用途和制备方法，这种衍生物具有明显的抗肿瘤活性，它属于高分子化学领域，也属于分子生物学领域。
80年代以来的研究表明，灵芝水不溶性多糖是灵芝多糖的主要成分。Sone等人(Agric.Biol.Chem.49，2641，1985)的研究认为灵芝水不溶性多糖是灵芝子实体β-(1→3)-D-葡聚糖，但不具有抗肿瘤活性且不能被β-(1→3)D-葡聚糖水解酶水解。通过化学修饰改变多糖生物活性的报道主要有Smith降解(药学学报21，944，1986)，高碘酸氧化后硼氢化还原(Carbohydr.Res.115，273，1983)，羧甲基化(Eur.J.Cancer 15，2110，1978)和硫酸酯化(Antimicrob.Agents Chemother.85，6132，1985；Biochem.Pharmcol.37，2887，1988；J.Immunopharmcol.12，225，1990)等，由此提高多糖在抗肿瘤、抗爱滋病毒及抗凝血等方面生物活性。
本发明的目的是提供一种一种具有抗肿瘤活性的α-(1→3)D-葡聚糖羧甲基化衍生物及其用途和制备方法，该方法将利用灵芝子实体中含量最多而又无生物活性的水不溶性α-(1→3)-D-葡聚糖(含量占3％)，通过羧甲基化后变为水溶性衍生物，从而使其具有明显抗肿瘤活性和免疫功能，并可用作保健品，而且可望开发成天然药物，是一种科技含量高的产物。
为实现上述目的，本发明所采用的技术方案如下：
一种灵芝α-(1→3)D-葡聚糖羧甲基化衍生物，它是将α-(1→3)D-葡聚糖溶于NaOH水溶液，恒温80℃，在持续搅拌下缓慢滴加氯乙酸钠水溶液，反应6-8小时后，取出反应物溶液用盐酸中和至中性，并在甲醇中沉淀出产物，分别用甲醇水溶液和无水甲醇洗涤，得到的即为灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物。
所制得的羧甲基化衍生物对植入小鼠(昆明种小白鼠)体内的爱氏腹水肿瘤(EAC)都具有明显的抑制作用。动物实验结果见附表1。因此，本发明的灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物用于制备抗肿瘤药物或提高人体免疫机能的保健品。
制备本发明的灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物方法是：首先从灵芝子实体中分离出水不溶性线型α-(1→3)-D-葡聚糖。其分子量为19.5×104，在1NNaOH中[α]D＝170(degcm2g-1)。将其溶解在NaOH水溶液中，用氯乙酸钠水溶液于80℃，羧甲基化6-8小时，用甲醇沉淀出产物。接着用甲醇水溶液洗涤，最后用无水甲醇洗涤，真空干燥后得羧甲基化衍生物。
本发明建立了以灵芝子实体水不溶性线型α-(1→3)-D-葡聚糖为原料制备出水溶性羧甲基化衍生物的方法。动物体内试验证明，α-(1→3)-D-葡聚糖羧甲基化衍生物具有显著的抗肿瘤EAC活性，且无毒副作用，可用作保健品，作为抗肿瘤天然药物也具有应用前景。本发明与已有技术相比有实质性不同，而且有明显的技术进步。
本发明首次用灵芝α-(1→3)-D-葡聚糖为原料，通过羧甲基衍生化使水不溶性且无生物活性的多糖变为水溶性，且抗肿瘤活性明显的多糖衍生物。此法工艺简单，操作方便，效果显著。
以下结合具体的实施例对本发明的技术方案作进一步的说明：
实施例1
灵芝子实体经粉碎、脱脂、再用磷酸盐缓冲液于100℃下提取出水溶性多糖后，用1M NaOH水溶液提取出水不溶性α-(1→3)-D-葡聚糖。将它的NaOH溶液在流水中透析7天，再对蒸馏水透析3天。此时NaOH被透析掉，多糖沉淀出来。然后将浑浊液进行离心，收集固体并进行真空干燥。由此得到白色粉末状灵芝α-(1→3)-D-葡聚糖。
灵芝α-(1→3)-D-葡聚糖1克，溶于50mL NaOH水溶液。恒温80℃，在持续搅拌下缓慢滴加氯乙酸钠水溶液40mL，并于30分钟内滴加完。在反应6小时后取出反应物溶液，用盐酸中和至中性，在甲醇中沉淀出产物。将所得产物用甲醇水溶液洗涤6次，无水甲醇洗涤6次，真空干燥7天，由此得到白色粉状的羧甲基化衍生物。产率为80～85％。
附表1.灵芝α-(1→3)-D-葡聚糖及其衍生物抗EAC肿瘤活性
样品    剂量(mg/kg/day)     抑制率(％)
灵芝α-(1→3)-D-葡聚糖    12.0×7     0
灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物    34.7×7     35.6
比较组：5-氟尿嘧啶    20.0×7     56.7

Claims (3)

1.一种灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物，其特征在于：它是将灵芝子实体中水不溶性的线性α-(1→3)-D-葡聚糖溶于NaOH水溶液，恒温80℃，在持续搅拌下缓慢滴加氯乙酸钠水溶液，反应6-8小时后，取出反应物溶液用盐酸中和至中性，并在甲醇中沉淀出产物，分别用甲醇水溶液和无水甲醇洗涤，得到的即为灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物；
2.权利要求1所述的灵芝α-(1→3)-D-葡聚糖的羧甲基化衍生物用于制备抗肿瘤药物或提高人体免疫机能的保健品；
3.一种制备权利要求1所述的灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物的方法，其特征在于：它是将灵芝子实体中水不溶性的线性α-(1→3)-D-葡聚糖溶于NaOH水溶液，恒温80℃，在持续搅拌下缓慢滴加氯乙酸钠水溶液，反应6-8小时后，取出反应物溶液用盐酸中和至中性，并在甲醇中沉淀出产物，分别用甲醇水溶液和无水甲醇洗涤，即得到灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物。
CNB99116590XA 1999-08-05 1999-08-05 灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物及其用途和制备方法 Expired - Fee Related CN1133654C (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB99116590XA CN1133654C (zh) 1999-08-05 1999-08-05 灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物及其用途和制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB99116590XA CN1133654C (zh) 1999-08-05 1999-08-05 灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物及其用途和制备方法

Publications (2)

Publication Number Publication Date
CN1283633A CN1283633A (zh) 2001-02-14
CN1133654C true CN1133654C (zh) 2004-01-07

Family

ID=5279387

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB99116590XA Expired - Fee Related CN1133654C (zh) 1999-08-05 1999-08-05 灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物及其用途和制备方法

Country Status (1)

Country Link
CN (1) CN1133654C (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100439401C (zh) * 2005-11-30 2008-12-03 华南理工大学 羧甲基裂褶多糖的制备方法及其在化妆品或抗肿瘤药物中的应用
US9139718B2 (en) 2012-12-20 2015-09-22 E I Du Pont De Nemours And Company Preparation of poly alpha-1,3-glucan ethers
CA2893950C (en) * 2012-12-20 2020-10-20 E. I. Du Pont De Nemours And Company Preparation of poly alpha-1,3-glucan ethers
NZ708558A (en) 2012-12-27 2019-10-25 Du Pont Preparation of poly alpha-1,3-glucan esters and films therefrom
CN103816204A (zh) * 2013-11-19 2014-05-28 新乡医学院 中药菟丝子提取物化学修饰的制备方法和临床应用
KR20160099629A (ko) 2013-12-16 2016-08-22 이 아이 듀폰 디 네모아 앤드 캄파니 점도 조절제로서의 폴리 알파-1,3-글루칸 에테르의 사용
US9957334B2 (en) 2013-12-18 2018-05-01 E I Du Pont De Nemours And Company Cationic poly alpha-1,3-glucan ethers
KR102443837B1 (ko) 2014-01-06 2022-09-19 뉴트리션 앤드 바이오사이언시스 유에스에이 4, 인크. 폴리 알파-1,3-글루칸 필름의 제조
CN103804512B (zh) * 2014-01-16 2016-05-04 昆山京昆油田化学科技开发公司 一种半乳糖基葡聚糖衍生物的制备方法
US10106626B2 (en) 2014-01-17 2018-10-23 Ei Du Pont De Nemours And Company Production of poly alpha-1,3-glucan formate films
CN105980413B (zh) 2014-02-14 2020-11-10 纳幕尔杜邦公司 用于制备葡聚糖聚合物的葡糖基转移酶
CN106132997A (zh) 2014-03-11 2016-11-16 纳幕尔杜邦公司 作为洗涤剂助洗剂的氧化的聚α‑1，3‑葡聚糖
EP3158043B1 (en) 2014-06-19 2021-03-10 Nutrition & Biosciences USA 4, Inc. Compositions containing one or more poly alpha-1,3-glucan ether compounds
US9714403B2 (en) 2014-06-19 2017-07-25 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
WO2016105971A1 (en) 2014-12-22 2016-06-30 E. I. Du Pont De Nemours And Company Polysaccharide compositions for absorbing aqueous liquid
CN105001347A (zh) * 2015-06-24 2015-10-28 河南中烟工业有限责任公司 羧甲基化灵芝多糖、合成纯化方法及其作为烟草保润剂的应用
CN117487037B (zh) * 2023-12-29 2024-03-15 山东国力生物科技有限公司 一种制备多位取代羧甲基葡聚糖的方法及其产品

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5038687B1 (zh) * 1970-08-20 1975-12-11
JPS5893702A (ja) * 1981-12-01 1983-06-03 Sankyo Co Ltd β−１，３−グルカンおよびその製法
JPS61152702A (ja) * 1984-12-26 1986-07-11 Daicel Chem Ind Ltd カルボキシメチルデキストランの製造法
US4769393A (en) * 1985-11-05 1988-09-06 Japan Styrene Corporation of Japan Expanded particles of modified polyethylene and foamed articles obtained therefrom
JPH03207804A (ja) * 1990-01-10 1991-09-11 Nippon Steel Corp 高炉原料装入物落下位置検出方法及び落下位置制御方法
US5155032A (en) * 1988-09-01 1992-10-13 Seikagaku Kogyo Co., Ltd. Horseshoe crab amebocyte lysate factor g activation inhibitor
EP0526649A1 (en) * 1991-02-21 1993-02-10 Drug Delivery System Institute, Ltd. Carboxymethylmannoglucan and derivative thereof
WO1994019376A1 (en) * 1993-02-26 1994-09-01 Drug Delivery System Institute, Ltd. Polysaccharide derivative and drug carrier
JP3207804B2 (ja) * 1998-04-14 2001-09-10 東京瓦斯株式会社 ディジタル圧力表示計

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5038687B1 (zh) * 1970-08-20 1975-12-11
JPS5893702A (ja) * 1981-12-01 1983-06-03 Sankyo Co Ltd β−１，３−グルカンおよびその製法
JPS61152702A (ja) * 1984-12-26 1986-07-11 Daicel Chem Ind Ltd カルボキシメチルデキストランの製造法
US4769393A (en) * 1985-11-05 1988-09-06 Japan Styrene Corporation of Japan Expanded particles of modified polyethylene and foamed articles obtained therefrom
US5155032A (en) * 1988-09-01 1992-10-13 Seikagaku Kogyo Co., Ltd. Horseshoe crab amebocyte lysate factor g activation inhibitor
JPH03207804A (ja) * 1990-01-10 1991-09-11 Nippon Steel Corp 高炉原料装入物落下位置検出方法及び落下位置制御方法
EP0526649A1 (en) * 1991-02-21 1993-02-10 Drug Delivery System Institute, Ltd. Carboxymethylmannoglucan and derivative thereof
WO1994019376A1 (en) * 1993-02-26 1994-09-01 Drug Delivery System Institute, Ltd. Polysaccharide derivative and drug carrier
JP3207804B2 (ja) * 1998-04-14 2001-09-10 東京瓦斯株式会社 ディジタル圧力表示計

Also Published As

Publication number Publication date
CN1283633A (zh) 2001-02-14

Similar Documents

Publication Publication Date Title
CN1133654C (zh) 灵芝α-(1→3)-D-葡聚糖羧甲基化衍生物及其用途和制备方法
Wang et al. Structural characterization and immunostimulatory activity of a glucan from natural Cordyceps sinensis
Wu et al. Structural elucidation and immunomodulatory activity of a β-D-glucan prepared by freeze-thawing from Hericium erinaceus
Yan et al. Structure elucidation and immunomodulatory activity of a β-glucan derived from the fruiting bodies of Amillariella mellea
Sun et al. Purification, structural features and immunostimulatory activity of novel polysaccharides from Caulerpa lentillifera
Saghir et al. Structure characterization and carboxymethylation of arabinoxylan isolated from Ispaghula (Plantago ovata) seed husk
Wang et al. Structural characterization and inhibition on α-d-glucosidase activity of non-starch polysaccharides from Fagopyrum tartaricum
Sone et al. Structures and antitumor activities of the polysaccharides isolated from fruiting body and the growing culture of mycelium of Ganoderma lucidum
Yang et al. Effect of methylation on the structure and radical scavenging activity of polysaccharides from longan (Dimocarpus longan Lour.) fruit pericarp
EP2370475B1 (en) Production of a saccharide composition comprising glucans and mannans by alkaline and acid hydrolysis of yeast cells
Bui et al. Polysaccharide composition of the fruit juice of Morinda citrifolia (Noni)
Yu et al. Immunomodulatory activities of sulfated Cyclocarya paliurus polysaccharides with different degrees of substitution on mouse spleen lymphocytes
Shashidhar et al. Functional polysaccharides from medicinal mushroom Cordyceps sinensis as a potent food supplement: extraction, characterization and therapeutic potentials–a systematic review
Moreno et al. Structure and antinociceptive effects of β-D-glucans from Cookeina tricholoma
Zhou et al. Isolation, characterization and in vitro anticancer activity of an aqueous galactomannan from the seed of Sesbania cannabina
US20220304355A1 (en) Identification and selection of a plant starting material of a plant chondroitin sulfate and hyaluronic acid, and transformation of such plant starting material to obtain ingredients for use in foods, supplements, medical devices or drugs
CN102277398B (zh) 高生物利用度改性果胶制备工艺及抗肿瘤应用
Kumari et al. Onion and garlic polysaccharides: A review on extraction, characterization, bioactivity, and modifications
Sun et al. Function and mechanism of polysaccharide on enhancing tolerance of Trichoderma asperellum under Pb2+ stress
JP6174219B2 (ja) 新規多糖体
Wang et al. Dendrobium hancockii polysaccharides, structure characterization, modification, antioxidant and antibacterial activity
Yiasmin et al. Purification, isolation, and structure characterization of water soluble and insoluble polysaccharides from Maitake fruiting body
Li et al. Structure characterization and biological activities evaluation of two hetero-polysaccharides from Lepista nuda: Cell antioxidant, anticancer and immune-modulatory activities
Huang et al. Preparation, structural elucidation and immunomodulatory activity of a polysaccharide from Millettia Speciosa Champ
JP4183326B2 (ja) ハナビラタケ抽出物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee